Adding vitamin D to the treatment of chronic urticaria can be helpful.

Role of vitamin D supplementation on symptom score and quality of life in patients with chronic urticaria.

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/07/044324

Enrollment

100

Registered

2022-07-26

Start date

Unknown

Completion date

Unknown

Last updated

2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L501- Idiopathic urticaria

Interventions

Intervention1: Patients receiving both antihistamines and vitamin d3 supplementation: Patients Will receive Oral vitamin D3 60,000 IU weekly for 4 weeks,then one dose at the end of 8 weeks(total 5 dos

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age :20-60 years. 2. Sex : Both gender. 3. Chronic spontaneous urticaria patients having recurrent wheals occurring at least 3 times per week for more than 6 weeks within the past year.

Exclusion criteria

Exclusion criteria: EXCLUSION CRITERIA : 1. Acute urticaria patients. 2. Physical urticaria patients 3. Urticarial vasculitis patients. 4. Hereditory or acquired angioedema patients. 5. Those who have taken vitamin D supplements . 6. Pregnant and lactating females.

Design outcomes

Primary

Measure	Time frame
To compare the reduction in urticaria activity score (UAS7) following the vitamin D supplementation along with standard treatment in comparison to only standard treatment in patients with chronic urticaria. Timepoint: 12 weeks	—

Secondary

Measure	Time frame
The secondary outcomes include the effect of Vitamin D supplementation on the reduction in medication dosage and quality of life scores in CU.Timepoint: 12 weeks	—

Countries

India

Contacts

Public ContactNishtha Loona

KIMS

kedarnath.dash@kims.ac.in9890634707

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026